Background: In addition to palliative care in the dying phase, the care of sick children and their families is becoming increasingly important in times of crisis of a life-limiting illness. The families are supported by a specialised ambulatory palliative team for children and adolescents (SAPV-team for children and adolescents). The aim of the retrospective survey was to determine the quality of these palliative care crisis interventions for the families.

Methodology: A retrospective questionnaire on medical care and family burden was developed. The "Hospital Anxiety and Depression Scale" was used to measure the burden of the families, and is aimed to assess anxiety and depression symptoms of the relatives. All families who were cared for by the pediatric palliative care team of the Children's and Adolescent Clinic of the University of Erlangen-Nuremberg in the context of crisis interventions between January 2012 and August 2017 received the questionnaire with the request for cooperation.

Results: The response rate of the questionnaires was 52,1%. The support and security from the palliative team, the 24-hour on-call service and the support in the organization of medical aids were rated particularly highly. The crisis intervention significantly improved the burden on patients and the family, as well as symptom control and communication.

Discussion: The present study demonstrates the tremendous psychological and physical stress with reduced quality of life of both sick children and their families in crisis situations. Specialized outpatient pediatric palliative care is able to help patients and families.

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1589-5854DOI Listing

Publication Analysis

Top Keywords

palliative care
20
pediatric palliative
12
care crisis
8
crisis intervention
8
sick children
8
children families
8
palliative team
8
children adolescents
8
crisis interventions
8
anxiety depression
8

Similar Publications

Background: Dedifferentiated liposarcoma (DDLPS) is a rare mesenchymal cancer originating from the adipose tissue, with poor survival rates for most patients, highlighting the critical need for novel treatment options.

Case Description: This report examines the efficacy and safety of sequential pre-treatment with the marine-derived alkaloid trabectedin followed by checkpoint inhibition using the anti-PD-1 antibody nivolumab in a 63-year-old male patient with unresectable retroperitoneal DDLPS. Treatment was initiated at the time of the seventh relapse as part of the NitraSarc phase 2 multicenter trial for inoperable soft tissue sarcoma conducted by the German Interdisciplinary Sarcoma Group (GISG-15, ).

View Article and Find Full Text PDF

Introduction: Despite level 1 evidence supporting neoadjuvant chemotherapy (NACT) followed by radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC), its adoption is hindered by concerns about toxicity and detrimental impact on post-RC complications. We retrospectively reviewed post-RC complications at a tertiary care hospital, particularly assessing impact of NACT.

Methods: Data from the institutional bladder cancer database were retrieved for patients aged ≥18 with MIBC (≥American Joint Committee on Cancer Clinical Stage T2), treated with RC between May 2013 and July 2023.

View Article and Find Full Text PDF

Purpose//objectives: A disproportionate incidence's increase of rectal cancer in patients younger than 50 years of age. The ESMO and NCCN recommendations are not age-specific and the literature is poor and conflicting. We decided to examine patients with rectal cancer treated in our centre in the last 15 years with curative neoadjuvant radiochemotherapy comparing outcomes in the two groups under and over 55 years old.

View Article and Find Full Text PDF

Need for a 'VR-cebo' and more robust evaluations of virtual reality intervention.

BMJ Oncol

December 2023

Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL, London, UK.

View Article and Find Full Text PDF

Objective: The 'Godrevy Project' is an interventional trial designed to determine the effectiveness of immersive virtual reality (VR) on the holistic symptom control and well-being in oncology and palliative care patients. The primary objective of this study was to determine whether VR changed the revised Edmonton Symptom and Assessment System (ESAS-r) score representing an effective improvement in symptom control and well-being.

Methods And Analysis: This study reports on 60 participants recruited from hospital inpatient oncology and palliative care lists, to participate in an unblinded, VR intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!